Please assess the completion status of the following clinical trial:

Trial Title: Continuous Lumbar Plexus Block With and Without Parasacral Block in Patients Undergoing Total Hip Replacement

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Subject has signed and dated an Informed Consent Form.~2. Subject is classified as a ASA (American Society of Anesthesiologists) status I-III~3. Subject is age 18- 75 years old.~4. Subject is having primary total hip arthroplasty~5. No contraindication to peripheral nerve catheter ( local infection or hypocoagulable state)~6. Patient willing to receive spinal anesthesia as operative anesthesia~7. No known drug allergies to study medications~8. Patients not expected to receive therapeutic anticoagulation in the postoperative period.~Exclusion Criteria:~1. Subject inability to provide adequate informed consent.~2. Age younger than 18 years or older than 75 years~3. Any contraindication to the placement of lumbar plexus catheter, including local infection, hypocoagulable state.~4. ASA (American Society of Anesthesiologists) physical status of IV or greater~5. Any chronic painful conditions~6. Preoperative opioid use~7. Coagulation abnormalities or patients who are expected to be on therapeutic anticoagulants postoperatively

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Continuous Lumbar Plexus Block with Parasacral Nerve Block (Type: EXPERIMENTAL): Lumbar plexus nerve block placement and activation: After subcutaneous infiltration of local anesthetic, 20 mL of Ropivacaine 0.2% will be injected; the catheter will be introduced for 5 cm past the needle tip and secured with steri strips and tegaderm. In PACU, the catheter will be connected to a pump of 0.0625% bupivacaine at 5 - 10 mL per hour at the discretion of the Acute Interventional Perioperative Pain Service (AIPPS). Additional 5mL boluses of 0.0625% bupivacaine will be given on demand once per hour prn.~A single shot parasacral (sciatic) nerve block will then be place under the ultrasound guidance. Ropivacaine 0.2% 9 ml will be injected.
- Lumbar Plexus Nerve Block (Type: ACTIVE_COMPARATOR): Lumbar plexus nerve block placement and activation: After subcutaneous infiltration of local anesthetic, 20 mL of Ropivacaine 0.2% will be injected; the catheter will be introduced for 5 cm past the needle tip and secured with steri strips and tegaderm. In PACU, the catheter will be connected to a pump of 0.0625% bupivacaine at 5 - 10 mL per hour at the discretion of the Acute Interventional Perioperative Pain Service (AIPPS). Additional 5mL boluses of 0.0625% bupivacaine will be given on demand once per hour prn.~No sham/placebo parasacral (sciatic) blocks will be performed in this group.

Based on this trial design, predict the completion outcome and termination type (if applicable).